CONCORD, Ohio--(BUSINESS WIRE)--Ricerca Biosciences, LLC, announced today the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan.

The expanded organization provides the biopharmaceutical industry with access to a global contract research organization (CRO) focused on the developmental phase between intellectual property (IP) and submission of the investigational new drug (IND) application. The increased capacity and capabilities deliver numerous benefits, including:

* Global toxicology allowing coordination of projects between North America, Europe and Asia
* Access to cGMP and non-GMP API synthesis and process development for IND-enabling toxicology performed in North America and Europe
* Expanded and enhanced DMPK services and efficacy models
* Streamlined lead optimization service combining efficacy and biomarker assays with medicinal chemistry
* Complete pharmacological profiling services including molecular, cellular, tissue and in vivo assays of development candidates
* Radio labeled compound synthesis available for all locations worldwide

Ricerca Chairman and CEO Ian Lennox stated, “With facilities worldwide combining local experience, immense scientific expertise and a strong commitment to excellent client service, we provide unique discovery and development services. Our expanded organization is a research partner clients can rely on to think strategically about projects, anticipate needs and rapidly deliver study results.”

About Ricerca Biosciences

Ricerca Biosciences currently has capabilities in discovery and medicinal chemistry, API process chemistry, cGMP manufacturing and scale-up and IND-enabling toxicology. The addition of the MDS Pharma Services molecular profiling, pharmacology/DMPK and drug safety assessment services will allow Ricerca to offer a more comprehensive suite of discovery and preclinical services to support drug candidates from discovery through IND on a global scale.

Contacts

for Ricerca Biosciences
Angela Thorell, 402-829-9009
angela@scorrmarketing.com